Epredia and NovaScan Announce Intent to Enter U.S. Distribution Agreement for MarginScan™ Device for Non-Melanoma Skin Cancer Detection
BioSpace News
by
6h ago
Epredia and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have signed a letter of intent for a U.S. exclusive commercial distribution agreement for MarginScan™, a medical device that will support physicians in real-time detection of non-melanoma skin cancer ..read more
Visit website
Hansa Biopharma: increase in number of shares and votes
BioSpace News
by
6h ago
Hansa Biopharma AB, announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby the number of votes increased with 10,474,740 and the share capital increased with SEK 10,474,740 ..read more
Visit website
Angle PLC Announces New Commercial Agreement with Large Pharma
BioSpace News
by
6h ago
ANGLE plc is delighted to announce that it has signed a supplier agreement to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies ..read more
Visit website
AAVantgarde announces its innovative clinical study design for its lead program in Usher 1B
BioSpace News
by
6h ago
AAVantgarde Bio announced the presentation of the clinical trial design of the Company’s lead program in Usher 1B by the program’s Principal Investigator, Prof. Francesca Simonelli, at the 9th Annual Retinal Cell and Gene Therapy Innovation Summit, being held today in Seattle ..read more
Visit website
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
BioSpace News
by
6h ago
Soleno Therapeutics, Inc. announced the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $46.00 per share ..read more
Visit website
Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024
BioSpace News
by
6h ago
Basilea Pharmaceutica Ltd announced that scientific presentations with new data on its antibiotic ceftobiprole have been presented at ESCMID Global 2024, the annual meeting of the European Society of Clinical Microbiology and Infectious Diseases, which took place from April 27 to 30, 2024 in Barcelona, Spain ..read more
Visit website
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
BioSpace News
by
9h ago
Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments ..read more
Visit website
IQVIA Reports First-Quarter 2024 Results
BioSpace News
by
9h ago
IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, reported financial results for the quarter ended March 31, 2024 ..read more
Visit website
Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
BioSpace News
by
9h ago
Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusive and equitable ..read more
Visit website
Delphia Therapeutics Launches to Pioneer a New Field of Cancer Medicines: Activation Lethality
BioSpace News
by
9h ago
Delphia Therapeutics, Inc., announced its launch to pioneer a new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation ..read more
Visit website

Follow BioSpace News on FeedSpot

Continue with Google
Continue with Apple
OR